Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Br J Clin Pharmacol (2012) 74:43744
The most common were nausea (28.6%, 38.4% and 42.4% vs 14.8%), diarrhoea (25.2%, 34.1% and 32.0% vs 13.5%), constipation (23.8%, 25.9% and 26.1% vs 10.9%), vomiting (10.6%, 22.8% and 25.3% vs 4.8%), and upper respiratory tract infection (14.2%, 12.2% and 13.1% vs 11.6%)
Understanding how these averages were reached can make it easier to interpret your own resultsand avoid assuming something is wrong when your experience doesnt match a headline number
doi: 10.3945/ajcn.2010.29885 65 BrealeyDBrandMHargreavesIHealesSLandJSmolenskiRet al
In vivo studies
US$ 28.73
US$ 28.04
US$ 26.14
US$ 26.24
US$ 29.18
